Lakewood-Amedex Biotherapeutics (LABT) vs Onconetix (ONCO)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
Onconetix is the larger company by market cap ($2.4 million vs $2.2 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | LABT | ONCO |
|---|---|---|
| Share price | $0.2449 | $2.89 |
| Market cap | $2.19M | $2.37M |
| 1-day change | +15.03% | -8.54% |
| P/E ratio (TTM) | — | 0.00 |
| EPS (TTM) | $-5.57 | $4,509.80 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | — | $815.37K |
| Revenue growth (YoY) | — | -67.70% |
| Net income (latest FY) | — | $-14.03M |
| Gross margin | — | 77.62% |
| Operating margin | — | -2190.03% |
| Net margin | — | -1720.98% |
| 52-week high | $98.20 | $1,610.00 |
| 52-week low | $0.17 | $2.76 |
| Distance from 52-week high | -99.75% | -99.82% |
| Analyst consensus | strong_buy | — |
| Avg. price target upside | +4799.96% | — |
| Average volume | 16.14M | 412.90K |
| Shares outstanding | 8.95M | 820.61K |
| Employees | 5 | 2 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Lakewood-Amedex Biotherapeutics
LABT stock →Lakewood-Amedex Biotherapeutics, Inc. operates as a clinical-stage biotechnology company that develops antimicrobial products in the United States.
Health Care · Biotechnology: Pharmaceutical Preparations · 5 employees
About Onconetix
ONCO stock →Onconetix, Inc., a biotechnology company, focuses on the research, development, and commercialization of solutions for men's health and oncology in the United States, the European Union, and Non-European Union. The company offers Proclarix, an in vitro protein-based blood diagnostic test for prostate cancer.
Health Care · Biotechnology: Pharmaceutical Preparations · 2 employees
LABT vs ONCO FAQ
Which is bigger, Lakewood-Amedex Biotherapeutics or Onconetix?
Onconetix (ONCO) is larger, with a market capitalization of $2.37M compared with $2.19M for Lakewood-Amedex Biotherapeutics (LABT).
Are Lakewood-Amedex Biotherapeutics and Onconetix in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.